Inter and intra-specific diversity of parasites that cause lymphatic filariasis  by McNulty, Samantha N. et al.
Infection, Genetics and Evolution 14 (2013) 137–146Contents lists available at SciVerse ScienceDirect
Infection, Genetics and Evolution
journal homepage: www.elsevier .com/locate /meegidReview
Inter and intra-speciﬁc diversity of parasites that cause lymphatic ﬁlariasis
Samantha N. McNulty a, Makedonka Mitreva a,b, Gary J. Weil a, Peter U. Fischer a,⇑
a Infectious Diseases Division, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, United States
b The Genome Institute, Washington University School of Medicine, St. Louis, MO, United Statesa r t i c l e i n f o
Article history:
Received 10 August 2012
Received in revised form 31 October 2012
Accepted 2 November 2012





Global Program to Eliminate Lymphatic
Filariasis1567-1348 2012 Elsevier B V. .
http://dx.doi.org/10.1016/j.meegid.2012.11.002
⇑ Corresponding author. Tel.: +1 314 4547876.
E-mail address: Puﬁsche@DOM.wustl.edu (P.U. Fis
Open access under CC BYa b s t r a c t
Lymphatic ﬁlariasis is caused by three closely related nematode parasites: Wuchereria bancrofti, Brugia
malayi and Brugia timori. These species have many ecological variants that differ in several aspects of their
biology such as mosquito vector species, host range, periodicity, and morphology. Although the genome
of B. malayi (the ﬁrst genome sequenced from a parasitic nematode) has been available for more than ﬁve
years, very little is known about genetic variability among the lymphatic dwelling ﬁlariae. The genetic
diversity among these worms is not only interesting from a biological perspective, but it may have impor-
tant practical implications for the Global Program to Eliminate Lymphatic Filariasis, as the parasites may
respond differently to diagnostic tests and/or medical interventions. Therefore, better information on
their genetic variability is urgently needed. With improved methods for nucleic acid extraction and
recent advances in sequencing chemistry and instrumentation, this gap can be ﬁlled relatively inexpen-
sively. Improved information on ﬁlarial genetic diversity may increase the chances of success for lympha-
tic ﬁlariasis elimination programs.
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Lymphatic ﬁlariasis (LF) is a neglected tropical disease caused
by the ﬁlarial nematode parasites Wuchereria bancrofti, Brugia ma-
layi, and Brugia timori. These worms are endemic in 72 countries in
the tropics and sub-tropics where more than 1.4 billion people are
at risk of infection (WHO, 2009). Estimates suggest that 120 mil-
lion people are presently infected with one or more of the lympha-
tic ﬁlariae (WHO, 2009). Although many people with ﬁlarial
infections are asymptomatic, some 40 million people have clini-
cally evident disease (mostly hydroceles and lymphedema), mak-
ing LF a leading cause of long-term disability (Gyapong et al.,
2005).
Due to its signiﬁcant medical, social, and economic impact, the
World Health Organization (WHO) has targeted LF for elimination
by the year 2020 (Ottesen, 2000). The Global Program to Eliminate
Lymphatic Filariasis (GPELF) relies on mass administration of
anthelmintic drugs to disrupt parasite transmission in endemic
communities. By the end of 2005, mass drug administration
(MDA) programs had reached nearly half of the global at-risk pop-
ulation (WHO, 2006). By halftime in 2010, MDA had successfully
reduced disease rates in many areas (WHO, 2010, 2011); however,
confounding factors impede the ﬁght for global elimination.
Among these factors are differences in the species and strains of
the lymphatic ﬁlariae that affect various aspects of transmission,
disease progression, diagnosis and treatment.
Filariasis research has not adequately explored variability
among the lymphatic dwelling parasite species. Most molecular
studies have focused on a lab-adapted zoophilic strain of B. malayi,
the only lymphatic ﬁlarial parasite of humans that can be main-
tained in research laboratories. Though the behavior of this strain
in a rodent model has been described in detail, little is known
about its natural behavior in human or wild animal hosts. In con-
trast, the vast majority of ﬁeld studies have focused on human
infections withW. bancrofti, a parasite that has not been well char-
acterized, mainly due to the lack of an experimental host and the
inability to keep parasites in the laboratory. Despite recent ad-
vances that have made genome sequencing relatively cheap and
easy, the inter- and intra-species variation among these parasites
has not been thoroughly studied. Therefore, in this review, we dis-
cuss the diversity of lymphatic dwelling ﬁlarial nematodes and the
potential impacts of this diversity on disease elimination efforts.2. Parasite species and ecological strains
2.1. W. bancrofti
Of the three lymphatic ﬁlarial species known to infect humans,
W. bancrofti has the widest distribution. It is prevalent in Sub-Sah-
aran Africa, south and southeast Asia, and it was introduced to
countries in the Caribbean and Latin America with the slave trade
(Michael and Bundy, 1997). W. bancrofti was once common in Ja-
pan, China, the Republic of Korea, Turkey, Egypt, and Oceania,
but it is diminishing or gone from these areas due to disease elim-
ination programs (WHO, 2010, 2011). Owing to its widespread dis-
tribution,W. bancrofti is responsible for some 90% of all cases of LF.
Estimates suggested that before the launch of the GPELF approxi-
mately 115 million people were infected with W. bancrofti (Mi-
chael and Bundy, 1997). Since then, MDA efforts, human
migrations, and population expansions have confounded these
estimates, so updated information is urgently needed.
W. bancrofti can be divided into three major subtypes based on
the periodicity of microﬁlaria (Mf) in the peripheral blood of in-
fected patients: nocturnally periodic, nocturnally subperiodic and
diurnally subperiodic (Sasa, 1976). These three subtypes have beenfurther divided into ecological races based on their vector prefer-
ence (Sasa, 1976). In many cases, the ecological races are exqui-
sitely well adapted to a particular mosquito species. Various
cross-transmission experiments have shown that vector compe-
tence is related to biting habits as well as the speciﬁc anatomical
features and physiological properties of the insect (Bryan et al.,
1990; Bryan and Southgate, 1988a,b; Buse and Kuhlow, 1979; Jay-
asekera et al., 1980; Pichon, 2002; Snow et al., 2006; Southgate and
Bryan, 1992; Zielke and Kuhlow, 1977). Therefore, a given strain
may be preferentially transmitted by a particular mosquito species
even when other mosquito species are readily available.
Mf periodicity generally corresponds to the biting habits of the
predominant mosquito vector in a given geographical area. The
nocturnally periodic strains, whose Mf are only present in periph-
eral blood at night, are transmitted primarily by Culex quinquefas-
ciatus in urban areas of Asia, East Africa and the Americas and by
Anopheles mosquitoes in rural areas (particularly in sub-saharan
Africa) (Bockarie et al., 2009; Hawking, 1957). However, a few re-
ports implicateMansonia species as vectors in West Africa (Touma-
noff, 1958; Ughasi et al., 2012). Nocturnally subperiodic strains,
whose Mf are present in peripheral blood at all times with peak
densities around midnight, were once common in Thailand and
in the Andaman and Nicobar Islands of India where Ochlerotatus
(Aedes) niveus and related species served as vectors (Dhamodharan
et al., 2008; Kalra, 1974; Pothikasikorn et al., 2008). Diurnally sub-
periodic W. bancrofti, transmitted by day-biting mosquitoes of the
Aedes polynesiensis group, are prevalent in the Paciﬁc region east of
Wallace’s line (Moulia-Pelat et al., 1993).
Regardless of the strain or ecological type, all W. bancrofti are
strictly anthropophilic. Despite various attempts to develop a lab-
oratory life cycle, no viable, non-primate host has been identiﬁed
(Ash and Schacher, 1971; Cross et al., 1979, 1981; Dissanaike and
Niles, 1965). The only other recognized species of the genusWuch-
ereria, W. kalimantani, is an Anopheles-transmitted parasite of the
silvered leaf monkey; this species is restricted to the Island of Bor-
neo and is not known to infect humans or non-primates (Atmo-
soedjono et al., 1993; Palmieri et al., 1980). Therefore, no
member of the genus Wuchereria can be maintained in a host that
is amenable to the laboratory setting.
2.2. B. malayi
B. malayi is found in tropical regions of South and Southeast
Asia, occasionally overlapping with the range of W. bancrofti (Mi-
chael and Bundy, 1997). In areas where the two species are both
present, they may co-infect the same host, but they do not utilize
the same vector species. Two major forms of B. malayi have been
recognized: anthropophilic and zoophilic (Partono and Purnomo,
1987).
Anthropophilic B. malayi are transmitted by Anopheles mosqui-
toes that breed in open swamps or rice patties, restricting this form
of the parasite to rural areas (Fischer et al., 2000; Partono et al.,
1977; Partono and Purnomo, 1987; Vythilingam et al., 1996). In
accordance with the biting habits of the principal vector, anthropo-
philic strains exhibit nocturnal periodicity and exclusively infect
humans. They may develop in laboratory models (e.g., cats and ro-
dents) under experimental conditions, but the life cycle is difﬁcult
to maintain due to shortened periods of Mf production and de-
creased parasite survival rates (T. Supali, personal
communication).
Zoophilic B. malayi are transmitted by Mansonia mosquitoes.
These strains show varying patterns of periodicity, but are mainly
nocturnally subperiodic. In Southeast Asia, they are readily passed
between humans and wild and domestic animal hosts by their zoo-
philic vectors. Owing to their broad host range, parasites of this
strain can be maintained in the laboratory in small animal models
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mosquitoes as vectors (e.g., Ae. egypti strain black-eyed Liverpool,
Ae. togoi) (Ash and Riley, 1970). Mansonia transmitted B. malayi is
assumed to have emigrated from South-east Asia to parts of the In-
dian subcontinent and to the southwestern coast of Sri Lanka in the
Middle Ages. It has been hypothesized that the Malayan army
introduced B. malayi infection to Sri Lanka during the 12th and
13th century (Schweinfurth, 1983). Unlike the ancestral strains of
Southeast Asia, Mansonia transmitted B. malayi are nocturnally
periodic in India and Sri Lanka and have not been found in animals
(presumably due to the lack of an amenable non-human host).2.3. B. timori and other Brugia spp
B. timori has the most restricted geographic range of the lym-
phatic dwelling ﬁlarial species. It is only found in Indonesia and Ti-
mor-Leste, where it replaces B. malayi in areas east of the Wallace
line. B. timori is biologically similar to nocturnally periodic B. ma-
layi in its Mf periodicity, use of an Anopheline vector (in this case,
A. barbirostris), and in its restriction to human deﬁnitive hosts. Like
B. malayi, this species may be co-endemic with W. bancrofti and
may co-infect the same human host, but the two parasites are
transmitted by different vector species. For example, on Alor island
W. bancrofti is transmitted by A. subpictus in coastal areas while B.
timori is transmitted by A. barbirostris near rice patties (Supali et al.
2002).
Several other Brugia species occur in parts of Asia, Africa and the
Americas, including the U.S.A. These species infect various mam-
mals and occasionally cause zoonotic infections in humans, but
these cases are rare and almost never lead to the production of
Mf (Dissanaike et al., 2000; Orihel and Beaver, 1989; Orihel and
Eberhard, 1998; Tan et al., 2011). Some Brugia species hybridize
under experimental conditions, and fertile crosses between B. ma-
layi, B. pahangi, and B. patei were reported (Suswillo et al., 1978;
Trpis et al., 1981). If hybridization occurs in nature, it may have
contributed to intra-speciﬁc variation.3. Disease pathology
Symptoms of LF range from sub-clinical lymphangiectasia to se-
vere edema and elephantiasis for both brugian and bancroftian ﬁl-
ariasis. Hydrocele, scrotal elephantiasis, and chyluria are only seen
with bancroftian ﬁlariasis. One report detailed a population of
Javanese transmigrant farmers that rapidly developed high rates
of elephantiasis after settling in a B. timori endemic area of West
Flores, Indonesia; this could be taken as an indication that B. timori
is a particularly virulent species, but it is very likely that this phe-
nomenon was due (at least in part) to the immunological naïveté of
the host population, as farmers immigrating from other endemic
areas did not develop the same rates of disease (Partono et al.,
1978; Partono and Purnomo, 1978).
The clinical manifestations of LF vary not only between species
but also between strains of the same species and between different
geographical locations. Supali et al. (2002) reportedW. bancroftiMf
prevalence rates of nearly 20% in parts of Indonesia, and up to 29%
of adult males in surveyed communities presented with hydrocele.
On Lihir Island, Papua New Guinea,W. bancroftiMf prevalence was
comparable (approximately 24%), but fewer than 2% of men pre-
sented with hydrocele (Hii et al., 2000). Lymphedema of the leg
was uncommon in both areas. However, in an area in Haiti where
Mf prevalence was 25%, approximately 5% of women suffered from
elephantiasis of the leg (Eberhard et al., 1996). Based on an inte-
grated analysis of clinical and parasitological data, Dreyer et al.
(2000) proposed that the diverse clinical manifestations might re-
sult from variations in the mechanisms of pathogenesis. Thesevariations are not well understood, but they could be inﬂuenced
by differences in the parasite strains or populations present in a gi-
ven location.4. Diagnostics
Differences in parasite species and strains can be distinguished
by the tests that are commonly used to diagnose ﬁlarial infections
in endemic areas. Some diagnostic assays are able to detect a wide
array of ﬁlarial species and strains, while others are speciﬁc to a gi-
ven type. Discrepancies in the utility and sensitivity of the various
diagnostic methods presently in use are reﬂective of differences in
the morphological and genetic structure of the worms. The tests to
be discussed include: morphological examination, host antibody
detection, parasite antigen detection, and parasite DNA detection.
4.1. Morphology
Adult stage ﬁlarial worms of different species are easily differ-
entiated by size and physical appearance. Unfortunatly, the worms
that cause LF are hidden in deep lymphatic vessels and are rarely
recovered. Aside from laboratory strains of B. malayi, only a few
examples of each species have been collected and examined.
Therefore, little is known about morphological variation among
naturally occuring lymphatic ﬁlariae at the adult stage.
Developing larvae (late L1 through L3) are readily obtained
through collection and dissection of insect vectors. Since W. ban-
crofti, B. malayi and B. timori do not employ the same vectors, these
three species can often be differentiated based on the species of the
infected mosquito. However, difﬁculties may arise in distingushing
the human ﬁlarial parasites from parasites of wild and domestic
animals, since larval stages have relatively few deﬁning characters
and since animal parasites are poorly described (Bain and Chabaud,
1986). The inability to clearly differentiate animal parasites com-
plicates studies of intra-speciﬁc variation in the lymphatic ﬁlaria
since larvae with minute physical differences may belong to differ-
ent species rather than to different strains of the same species.
LF has historically been diagnosed by detection of circulating Mf
in peripheral blood. The sheathed Mf of W. bancrofti, B. malayi and
B. timori are shown in Fig. 1. Assuming an identical preservation
and staining protocol, B. malayi Mf are generally larger than W.
bancrofti Mf and they are readily distinguished by densely packed
nuclei, the presences of two isolated nuclei at the tip of the tail, and
the absence of nuclei in the cephalic space (Fig. 1A–C). Microﬁlar-
iae of B. timori, which also have very densley packed nuclei, are
longer than those of B. malayi with a longer nucleus-free cephalic
space (Fig. 1B and D). There are a few reports detailing intra-spe-
ciﬁc variation among W. bancrofti Mf, including an Indian strain
of W. bancrofti with particularly large Mf, but little conclusive data
are available (Jitpakdi et al., 1999; Kaushal et al., 2012; Paily et al.,
2009). However, given the potential for variation and given the
dramatic plumping and/or dehydration that may result from pres-
ervation and staining, absolute size is not the best feature for mor-
phological differentiation.
4.2. Antibody detection
A number of crude and recombinant ﬁlarial antigens have been
used to detect circulating anti-ﬁlarial antibodies as a marker for
exposure and present or past infection. In general, there is strong
serological cross-reaction between antigens of the three lymphatic
ﬁlarial species, as well as to other ﬁlarial species. For example, the
commercial BrugiaRapid test that employs a recombinant B. malayi
antigen to detect anti-ﬁlarial IgG4 antibodies is equally sensitive to
antibodies against B. timori (Supali et al., 2004). The same test may
Fig. 1. Mf of lymphatic ﬁlariae stained by Giemsa: (A)W. bancrofti, (B) mixed infection, (C) B. malayi, and (D) B. timori. Panel (B) depicts the anterior end of a single B. timoriMf
(arrow) next toW. bancroftiMf (arrowhead) in a patient from central Flores. Note the long nucleus free cephalic space and the densely packed nuclei in B. timori. Arrows point
to the cephalic space.
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creased sensitivity (Rahmah et al., 2003). A second commercially
available ELISA format test relies on another recombinant B. malayi
antigen, but it cannot be used to differentiate infections with B.
malayi, B. timori and W. bancrofti (Weil et al., 2011). Thus, existing
antibody assays are not helpful for studying variability of lympha-
tic ﬁlariae despite their utility for diagnosis.4.3. Antigen detection
Two antigen detection kits are commercially available for diag-
nosing W. bancrofti infection: the Og4C3 ELISA test (TropBio,
Townsville, Australia) and the rapid format Binax Now Filariasis
ICT Test (Alere, Portland, ME, USA) (Weil and Ramzy, 2007). These
tests rely on monoclonal antibodies (mAbs) against ﬁlarial antigens
from animal parasites: the cattle parasite Onchocerca gibsoni for the
Og4C3 ELISA and the dog heartworm Diroﬁlaria immitis for the ICT
test (More and Copeman, 1990; Weil and Liftis, 1987). The mAbs
used in these tests detect their target epitopes in antigen prepara-
tions of various ﬁlarial nematode species; however, W. bancrofti is
the only species that can be detected in human sera. This suggests
that any antigens with these epitopes that are released by other
ﬁlarial species are rapidly cleared from the circulation in humans.
A few reports describe new tests that are able to detect circulating
antigens from other ﬁlarial species in human blood (for examples,
see Abdullah et al., 1993; Lalitha et al., 2002; Pandey et al., 2011;
Wongkamchai et al., 2003), but these have not been independently
veriﬁed and none are commercially available.4.4. DNA detection
Assays developed to detect ﬁlarial nematode DNA, whether by
Southern blot, PCR-ELISA, or conventional PCR, have historically
targeted repeated sequences in parasite genomes. For the most
part, these sequences are species-speciﬁc. The ﬁrst sequence em-ployed for this purpose was the HhaI repeat present in B. malayi
and B. pahangi. Probes designed to target this sequence success-
fully detected DNA from Brugia species but failed to hybridize with
W. bancrofti DNA (McReynolds et al., 1986). Later, genus-speciﬁc
conventional and real-time PCR assays were designed and imple-
mented based on the HhaI repeat (Rao et al., 2006b; Triteeraprapab
et al., 2001). Conversely, the long dispersed repeat (LDR1), which
contains the SspI repeat, is a useful target that is speciﬁc for W.
bancrofti (Fischer et al., 1999; McCarthy et al., 1996; Rao et al.,
2006a; Williams et al., 1996; Zhong et al., 1996).
As more sequence data became available, assays were designed
to amplify conserved DNA sequences and distinguish species based
on the restriction digest patterns of the ampliﬁed fragments. Such
loci include the glutathione peroxidase, cytochrome oxidase I, and
the ﬁrst internal transcribed spacer (Fischer et al., 2002; Nuchpray-
oon et al., 2005; Thanomsub et al., 2000). Recent sequencing stud-
ies have also noted species and strain speciﬁc polymorphism in the
ﬁrst internal transcribed spacer and cofactor-independent phos-
phoglycerate mutase isoform-1 (Dhamodharan et al., 2012; Fong
et al., 2012). Sakthidevi et al. (2010) devised a single-step PCR as-
say targeting portions of the abundant larval transcript-2 gene. PCR
products from B. malayi are at least 200 bp larger than those of W.
bancrofti due to increased numbers of tandem repeats in the sec-
ond and third introns, and this difference is easily detected by aga-
rose gel electrophoresis. It is likely that more loci like alt-2 will be
discovered as additional genome sequences are generated from W.
bancrofti and other ﬁlarial species.5. FR3 strain of B. malayi and the state of ﬁlarial genomics
The FR3 strain of B. malayi has arisen as the choice ‘‘model’’ for
laboratory studies of lymphatic dwelling and other ﬁlarial nema-
todes, and is provided free of charge for research purposes by the
Filariasis Research Reagent Resource Center in the US (http://
www.ﬁlariasiscenter.org) (Michalski et al., 2011). Originally iso-
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Malaysia to the UK in an experimentally infected cat by C. P. Rama-
chandran in the 1950s. The characterization of experimental vec-
tors (Ae. aegypti black-eyed Liverpool strain and Ae. togoi) and
rodent hosts made it possible to establish and maintain a life cycle
in the laboratory (Ash and Riley, 1970; Ramachandran, 1966;
Ramachandran et al., 1960, 1961; Ramachandran and Zaini, 1967,
1968a,b). Parasites of this strain have been passaged in laboratories
throughout the world for more than 60 years.
Little is known about the ecology of the FR3 strain in nature,
and human B. malayi infection has nearly been eliminated from
mainland Malaysia. However, the life cycle of these parasites in
experimental animals has been studied in great detail. Mf take
12–14 days to develop to the infective stage in Ae. aegypti (Ash
and Riley, 1970). After introduction into the jird host, the larvae
molt twice (once at 7–9 days and again at 28–31 days) to reach
the adult stage (Ash and Riley, 1970). The full duration of the
pre-patency period (i.e., time from introduction of infective larva
to appearance of Mf in the blood, which includes development,
ﬁnding a partner, mating, and production of Mf) is 12 weeks (Ash
and Riley, 1970). The pre-patency period of this strain in humans
has not been determined, but a small number of experimental
studies indicate a great deal of variability, with periods ranging
from 3 to 5 months (Nutman, 1991).
Genomic studies of B. malayi started with the generation of ex-
pressed sequence tags (ESTs). Blaxter et al. (1996) reported the ﬁrst
364 genes expressed from infective L3 by generating spliced leader
and non-spliced leader cDNA libraries. Studies comparing proﬁles
of genes expressed in infective, cultured versus irradiated (Li
et al., 2006) and infective versus post-infective (Gregory et al.,
1997) L3 followed as the techniques for extracting biological mate-
rial, isolating RNA, and sequencing improved. The sequences gen-
erated by these studies enabled the construction of the ﬁrst
cDNA oligonucleotide microarray and the subsequent comparison
of genes expressed in male and female B. malayi (Li et al., 2006)
and also helped to annotate the ﬁrst 10 MB of the B. malayi genome
(Whitton et al., 2004).
In 2007, the 90 Mb genome of the FR3 strain of B. malayi was
sequenced with 9x coverage (Ghedin et al., 2007). Annotation of
the genome resulted in 11,500 protein coding genes. While this
dataset only represented 65% to 80% of the inferred 14,500 to
17,800 genes, the analysis of this ﬁrst draft genome produced from
any helminth provided a wealth of information about ﬁlarial adap-
tation to its human and vector hosts and its relationship with the
Wolbachia endosymbiont. Due to the complex life cycle of B. malayi
compared to the free-living model nematode C. elegans, the B. ma-
layi genome reveals a unique evolutionary history leading to the
conservation of long-range gene linkage with rearrangements in
local gene order (Scott and Ghedin, 2009). The genome sequence
launched the ﬁeld of ﬁlarial biology into the genomic age, resulting
in the ﬁrst publically available LF microarray chip (http://
www.ﬁlariasiscenter.org).
It should be noted that the B. malayi genome is still incomplete,
and information has been added since 2007. The present versionTable 1
Sequence identity shared between the mitochondrial genomes of lymphatic ﬁlarial parasi
Bm FR3 Wb I
Bm FR3 100.0 88.3
Wb I 88.3 100.0
Wb WA 88.5 98.2
Wb PNG Ramesh 88.6 98.5
Wb PNG McNulty 88.5 97.4
Information was taken from the following sources: (McNulty et al. (2012); Ramesh et al.
(PNG) were described by Ramesh et al. while a W. bancrofti strain from PNG was sequen
bancrofti, respectively.includes 18,348 genes (with 21,332 predicted proteins including
unique isoforms, see: WormBase release WS230) with complete-
ness estimated at 93% based on the conserved eukaryotic gene
mapping protocol (Parra et al., 2007). Recent papers describing
transcription proﬁles across the life cycle (Choi et al., 2011; Li
et al., 2012) and proteomics studies (Bennuru et al., 2011, 2009;
Hewitson et al., 2008; Moreno and Geary, 2008) have taken advan-
tage of the more complete genome and provided novel insights
into the biology of B. malayi at the molecular level.
While new sequencing projects are in progress (Brindley et al.,
2009) and sequence reads from the W. bancrofti genome are avail-
able from the NCBI sequence read archive (project number
SRP000772), B. malayi is still the only ﬁlarial parasite with a nearly
complete, fully annotated, and published genome. Since the FR3
strain has been adapted to the rodent model and inbred in labora-
tories for so long, it may differ in signiﬁcant ways from the original
outbred parasite. Clearly there could be important differences be-
tween the TRS strain and outbred periodic B. malayi and B. timori.
Further studies are urgently needed to document the natural vari-
ation of lymphatic ﬁlarial parasites in relation to laboratory strains,
and we believe that sequencing of clinical isolates of lymphatic
dwelling ﬁlarial parasites is a high priority.6. Natural variation in ﬁlarial genomes
6.1. Inter-species variation among the lymphatic-dwelling ﬁlariae
As mentioned above, only the FR3 strain of B. malayi has been
sequenced, annotated and published, and very little is known
about genetic variation among lymphatic ﬁlarial parasites. For W.
bancrofti and B. timori, only common phylogenetic markers (e.g.,
5s and 18s ribosomal RNA genes) and the mitochondrial genomes
have been reported (Fong et al., 2008; McNulty et al., 2012; Ra-
mesh et al., 2012; Xie et al., 1994). Thus far, it seems that the lym-
phatic-dwelling species share a high degree of sequence homology.
Brugia and Wuchereria consistently form a monophyletic group in
phylogenetic studies of the Onchocercinae, regardless of the genet-
ic marker being analyzed (Casiraghi et al., 2001; Ferri et al., 2011;
Fong et al., 2008; Huang et al., 2009; McNulty et al., 2012; Michal-
ski et al., 2010; Xie et al., 1994; Yatawara et al., 2007). Alignments
indicate that the mitochondrial genomes of B. malayi and W. ban-
crofti share approximately 88% sequence identity (Table 1) (Ghedin
et al., 2007; McNulty et al., 2012; Ramesh et al., 2012). Using an as-
sumed generation time of one year and a mutation rate compara-
ble to that reported for Pristonchus paciﬁcus and Caenorhabditis
elegans, Ramesh et al. (2012) estimated that Brugia and Wuchereria
may have diverged some 675,000 years ago, a relatively recent
split given the phylogenetic age of the superfamily Filarioidea.6.2. Intra-species variation among the lymphatic-dwelling ﬁlariae
The few studies that have examined genetic diversity among
populations of ﬁlarial parasites were performed prior to the adventtes.






(2012)).W. bancrofti strains from India (I), West Africa (WA) and Papua New Guinea
ced by McNulty et al. The abbreviations Bm and Wb were used for B. malayi and W.
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dom ampliﬁcation of polymorphic DNA (RAPD). RAPD studies of B.
malayi have detected minor differences in the structure of repeti-
tive DNA elements in parasites from different strains or different
geographical regions. A variable locus on the Y chromosome, TOY
(Tag on Y), containing a microsatellite-like region with an 8 bp dif-
ference between the FR3 strain (originally from mainland Malay-
sia) and an isolate from Indonesia was described (Underwood
and Bianco, 1999). Later studies of the same locus were able to de-
tect differences in sub-periodic/zoophilic and nocturnally periodic/
anthropophilic Indonesian strains as well (Underwood et al., 2000).
Several studies have reported the use of the RAPD technique for
analyzing the genetic diversity of W. bancrofti populations in India.
Phylogenetic trees based on RAPD proﬁles divide Indian W. ban-
crofti populations into two major strains that occur on the eastern
and western sides of the Western Ghat mountain range (Patra
et al., 2007; Thangadurai et al., 2006). Within each of these major
strains, signiﬁcant genetic variability was detected in parasite pop-
ulations from different geographical regions, with the highest de-
grees of variability generally corresponding to urban areas with
dense, dynamic human populations (Hoti et al., 2008). In studies
focused on diurnally sub-periodic W. bancrofti in the Andaman
and Nicobar Islands, phylogenetic trees constructed from RAPD
data indicate that C. quinquefasciatus-transmitted parasites from
Car Nicobar Island form a separate cluster from Ochlerotatus
(Aedes) niveus-transmitted parasites from neighboring islands
(Dhamodharan et al., 2008). The Car Nicobar parasites also showed
a higher degree of genetic variability, indicating that these para-
sites might be in the process of adapting to the schedule of a
night-biting vector (Dhamodharan et al., 2008). Outside of India,
RAPD assays were developed to differentiate a nocturnally sub-
periodic Thai strain from nocturnally periodic Myanmar strains
(Nuchprayoon et al., 2007). Since elimination programs have sig-
niﬁcantly reduced the prevalence of W. bancrofti in Thailand, this
approach could be used to determine whether future increases in
ﬁlariasis rates in Thailand are due to a resurgence of Thai parasites
or to an inﬂux of parasites from neighboring regions.
A recent study was performed on intra-species variation in the
mitochondrial genome of W. bancrofti (Ramesh et al., 2012). The
mitochondrial genomes of three strains of W. bancrofti, from India,
West Africa and Papua New Guinea (PNG), were sequenced. Se-
quence identity between all examined strains ranged from 97%
to 99% (Table 1), and the West African and PNG strains appeared
to share the greatest degree of homology. Unfortunately, no infor-
mation was presented on the degree of variation within each pop-
ulation. The incomplete level of sequence identity shared between
two different PNG strains highlight the signiﬁcance of this issue
(Table 1) (McNulty et al., 2012; Ramesh et al., 2012).
6.3. Variation due to selective pressure from drugs
The Global Program to Eliminate Lymphatic Filariasis relies on
mass administration of combinations of anthelmintic drugs (alben-
dazole plus ivermectin in areas co-endemic for onchocerciasis and
albendazole plus diethylcarbamazine elsewhere) to block parasite
transmission. More than three billion doses of these drugs have
been administered to hundreds of millions of patients in more than
50 countries since 2000 (WHO, 2010, 2011). Macrocyclic lactones
and benzimidazoles (e.g., ivermectin and albendazole, respec-
tively) have also been used extensively in the veterinary setting,
and resistance has been reported in nematode parasites of domes-
tic animals (as reviewed by Kaminsky, 2003; Prichard, 1990; Wol-
stenholme et al., 2004). Although there is little hard evidence for
the development of drug resistance in ﬁlarial nematodes, it stands
to reason that selective pressure resulting from the use of these
drugs could alter the genetic structure of parasite populations.It is difﬁcult to speciﬁcally test for drug resistance in species like
W. bancrofti with no laboratory animal model, but suboptimal re-
sponses to diethylcarbamazine (DEC) had been reported prior to
the initiation of the GPELF (Eberhard et al., 1991, 1988). The molec-
ular target of DEC is unknown, and this makes it hard to assess the
impact of treatment on parasite genetics. Conversely, albendazole
is known to interfere with microtubule polymerization through
the binding of beta-tubulin (Kohler and Bachmann, 1981; Lubega
and Prichard, 1990). A phenylalanine to tyrosine substitution at
position 200 of the beta-tubulin gene associated with albendazole
resistance in animal parasites was detected in higher frequencies
in albendazole/ivermectin treatedW. bancrofti populations in West
Africa as compared to untreated populations (Schwab et al., 2005).
MDA treatments should select an increased frequency of this allele
(Schwab et al., 2006, 2007), and PCR-based assays have been devel-
oped to track the frequencies of resistance alleles in treated para-
site populations (Hoti et al., 2009). However, no parasitological
evidence for albendazole resistance in W. bancrofti has been noted
(Bisht et al., 2006). Similarly, there have been no reports of drug
resistance in Brugia species either in nature or under experimental
conditions.7. Genetic variation in Wolbachia genomes
It is well known thatWolbachia endobacteria play a vital role in
the biology of many ﬁlarial species, including B. malayi, B. timori
and W. bancrofti. Not only do these endosymbionts support the
growth and reproduction of dependent ﬁlarial species; they are
also believed to play a role in pathogenesis, and they may serve
as a practical anti-ﬁlarial drug target (Slatko et al., 2010; Taylor
et al., 2005, 2010). Similar to the lymphatic ﬁlariae themselves,
only one ﬁlarial Wolbachia genome (the endosymbiont of the B.
malayi FR3 strain) has been fully sequenced, annotated and pub-
lished (Foster et al., 2005). Therefore, little is known about genetic
variation among theWolbachia endobacteria of the lymphatic ﬁlar-
iae. In light of the agreement between phylogenies of Wolbachia
and their ﬁlarial nematode hosts (Casiraghi et al., 2004; Ferri
et al., 2011), it is likely that the Wolbachia strains carried by the
lymphatic ﬁlariae will be more similar to one another than to those
carried by more distantly related ﬁlarial species, but the exact de-
gree of inter- and/or intra-strain variation among ﬁlarialWolbachia
cannot be predicted. With the genomic sequences of theWolbachia
containing ﬁlarial parasites W. bancrofti, Onchocerca volvulus,
Onchocerca ochengi and D. immitis either published or in progress,
further Wolbachia genomes are being co-sequenced (Darby et al.,
2012; Godel et al., 2012). The ﬁrst results suggest that the Wolba-
chia genomes are very similar in some species (e.g., O. volvulus and
O. ochengi) but that others differ slightly in size and in the gene
number (Brindley et al., 2009; Darby et al., 2012). Additionally,
crossing experiments among cytoplasmic incompatibility inducing
Wolbachia strains in C. pipiens indicate a high degree of incompat-
ibility even in strains that are genetically indistinguishable using
typical multi locus strain typing genes (Baldo et al., 2006; Guille-
maud et al., 1997). This means that a small amount of sequence
variation in Wolbachia can lead to signiﬁcant biological
consequences.8. Discussion
In insect vectors of ﬁlariae, such as mosquitoes and blackﬂies,
advances in cytotaxonomy and molecular taxonomy have led to
the discovery of a large number of new, sibling species that could
not be differentiated by external morphology (Krueger, 2006; Nor-
ris, 2002; Sharakhov et al., 2002; Wondji et al., 2005). A similar sit-
uation could present itself in the case of the lymphatic dwelling
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lection of biologically distinct strains that differ in their geograph-
ical distribution, host and vector afﬁnities, periodicity,
pathogenicity, response to diagnostic tests, and potentially, to drug
treatments. Given the large geographic range of lymphatic dwell-
ing ﬁlariae, the isolation of some populations, and the absence of
robust population genetic data, it is possible that the lymphatic–
dwelling ﬁlariae comprise more than three taxa.
The classiﬁcation and organization of the lymphatic dwelling
ﬁlariae clearly deserves to be reconsidered in the genomic era.
One biological criterion for setting a species boundary is to deter-
mine whether individuals from different groups are capable of
mating to produce viable offspring. Unfortunately, we cannot
determine whether nocturnally periodic W. bancrofti from main-
land India are compatible with diurnally subperiodic W. bancrofti
from the Andaman and Nicobar island ranges, since they do not
share a common vector and cannot be maintained in the labora-
tory. It may be that this union is feasible (as are experimental un-
ions between certain strains of B. malayi, B. pahangi and B. patei
discussed previously) and that it does not occur in nature simply
because of geographical or other barriers. On the other hand,
cross-mating may be impossible and it may be more appropriate
to consider the two strains as different species.
Today’s sequencing methods could facilitate a reclassiﬁcation of
the lymphatic ﬁlariae based on genetic rather than phenotypic or
other biological characters (e.g., cross-mating). High throughput
sequencing technologies (introduced since 2005) are ever evolving,
as reviewed by Mardis, 2008, 2011. Rapid declines in cost coupled
with advances in molecular methods for isolating parasite material
allow researchers to generate cDNA and whole genome sequence
libraries for deep sequencing from nanograms of starting material.
Despite its minor role in lymphatic ﬁlarial disease, zoophilic B. ma-
layi was the obvious choice for genome sequencing 20 years ago
because it can be maintained in the laboratory (Blaxter, 1995; Un-
nasch, 1994). Less material is required for genome sequencing
these days; a few dozens of Mf should be sufﬁcient for full genome
sequencing. Mf can be obtained from ﬁnger-prick volumes of in-
fected blood, and these volumes are routinely collected in ongoing
mapping and epidemiological studies. Sequencing of such clinical
strains would enhance our understanding of the genetic variation
of LF parasites and consequently contribute to:
 Identiﬁcation of genetic markers suitable for ﬁngerprinting of
nematodes in order to differentiate persistent or reintroduced
infections;
 Determine polymorphic genes/gene families that might affect
drug or vaccine development;
 Determine genetic differences and similarities between pheno-
typically different strains (e.g., nocturnally periodic and subpe-
riodic W. bancrofti; W. bancrofti strains transmitted by different
vectors; subperiodic, zoophilic, Mansonia-transmitted B. malayi
and nocturnally periodic, anthropophilic, Anopheles-transmitted
B. malayi and B. timori;
 Identify genes/gene families that appear to have been affected
by the various MDA drug regimens to look for development of
resistance.
Although technical advances will facilitate genomic studies of
lymphatic-dwelling ﬁlarial parasites, questions will arise regarding
the deﬁnition of standard taxonomical terms. However, these
questions should not discourage the scientiﬁc community from
attempting to address ﬁlarial nematode taxonomy in a more rigor-
ous manner. After all, no set criteria were laid out for the degree of
phenotypic variation required for distinguishing species when the
ﬁlariae were originally described (Grove, 1990). It was only after
years of study and data collection that a satisfying consensuswas reached based on the information that was available at the
time. Now that more data have been obtained and even more data
are within reach, we face the same task. There is no reason to be-
lieve that we will be unable to come to similarly satisfying conclu-
sions in the genomic era.
A more accurate classiﬁcation of the lymphatic-dwelling ﬁlariae
is not only interesting from a basic biological or taxonomical per-
spective. It could also have practical importance for the global ef-
fort to eliminate LF. In order to combat this disabling disease, it
is necessary to understand the infecting agents. Are we engaged
in an effort to eliminate three species or a complex of many spe-
cies? Are there logical reasons to go about the elimination effort
differently in different geographical locations or in the presence
of different species or strains? If LF resurgence is observed follow-
ing MDA, is this due to a resumption of transmission of the ende-
mic strain or caused by importation of parasites from another
area? Clearly, a better understanding of the intra- and inter-species
diversity of the lymphatic dwelling ﬁlarial parasites would assist in
answering these important questions.Acknowledgements
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